# Space Lintech Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/space-lintech-co

- Industry: Aerospace
- Headquarters: Daejeon, South Korea
- Website: www.spaceliintech.com/
- Total disclosed funding: $3.2M
- Latest round: Series A (Apr 11, 2024)
- Investors on record: 3

## About

Founded in 2021 and based in Daejeon, South Korea, Space Lintech Co., Ltd., aka Space LiinTech, operates as an aerospace company that develops platforms for space medicine research and production based on satellites and space stations in a microgravity environment. In April 2024, Space LiinTech raised KRW 4 billion in Series A funding from Woori Venture Partners and Company K Partners. As of 2024, the company is led by its CEO, Hak-Sun Yoon.

The company specializes in the development and provision of space medicine research and pharmaceutical foundry platforms. The firm’s primary technology is the ground microgravity drop tower, which simulates microgravity conditions. In addition, Space Lintech excels in space microgravity research through its space microgravity—low earth orbit satellite module. This platform facilitates the study of protein molecules, crystal growth, and physiological changes in human cells under space conditions. Furthermore, Space Lintech develops wet laboratories using module technology, enabling pharmaceutical development and production in microgravity environments in space. Space Lintech's applications span various fields, from protein crystal growth for pharmaceutical development to stem cell growth for regenerative medicine. The company partners with Harvard Medical School, Perigee, Sunbo Angel Partners, and others.

## Funding rounds

- Series A, Apr 11, 2024, $3M — WOORI Venture Partners, Company K Partners
- Seed, Aug 1, 2023, $0.2M — Sunbo Angel Partners

## Investors

- Sunbo Angel Partners (https://capitalatlas.ai/funds/sunbo-angel-partners) — Seed
- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series A
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series A
